A detailed history of Israel Englander (Millennium Management LLC) transactions in Novo Nordisk A S stock. As of the latest transaction made, Millennium Management LLC holds 88,200 shares of NVO stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
88,200
Previous 200,000 55.9%
Holding current value
$11.9 Million
Previous $20.7 Million 45.27%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $68.4 Million - $91 Million
-669,637 Reduced 68.16%
312,777 $40.2 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $33 Million - $39.6 Million
375,577 Added 61.89%
982,414 $102 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $14.9 Million - $16.4 Million
95,273 Added 18.62%
606,837 $98.2 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $201 Million - $242 Million
-1,519,989 Reduced 74.82%
511,564 $81.4 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $115 Million - $151 Million
1,116,580 Added 122.03%
2,031,553 $275 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $34 Million - $41.7 Million
-356,891 Reduced 28.06%
914,973 $91.2 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $113 Million - $134 Million
1,096,564 Added 625.54%
1,271,864 $142 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $6.03 Million - $7.28 Million
-64,723 Reduced 26.97%
175,300 $19.5 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $52.7 Million - $64.3 Million
-549,369 Reduced 69.59%
240,023 $26.9 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $65.6 Million - $82.9 Million
777,317 Added 6437.41%
789,392 $75.8 Million
Q2 2021

Aug 16, 2021

SELL
$67.66 - $84.76 $23 Million - $28.8 Million
-339,334 Reduced 96.56%
12,075 $1.01 Million
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $17.4 Million - $19.6 Million
259,052 Added 280.49%
351,409 $23.7 Million
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $37.7 Million - $49.4 Million
-761,986 Reduced 89.19%
92,357 $5.56 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $20.7 Million - $24.2 Million
416,138 Added 94.96%
854,343 $49.4 Million
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $6.49 Million - $7.29 Million
-136,456 Reduced 23.75%
438,205 $22.7 Million
Q2 2019

Aug 15, 2019

SELL
$46.79 - $52.47 $6.02 Million - $6.75 Million
-128,623 Reduced 18.29%
574,661 $29.3 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $2.51 Million - $2.81 Million
-53,558 Reduced 7.08%
703,284 $28.3 Million
Q1 2019

May 14, 2019

SELL
$46.36 - $52.63 $3.33 Million - $3.79 Million
-71,929 Reduced 8.68%
756,842 $39.6 Million
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $11.1 Million - $12.6 Million
266,026 Added 47.27%
828,771 $38.2 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $20.4 Million - $22.3 Million
436,077 Added 344.27%
562,745 $26.5 Million
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $3.36 Million - $3.83 Million
75,956 Added 149.78%
126,668 $5.84 Million
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $13.7 Million - $16.4 Million
-282,937 Reduced 84.8%
50,712 $2.5 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $12 Million - $13.6 Million
252,844 Added 312.91%
333,649 $17.9 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $3.33 Million - $3.98 Million
80,805
80,805 $3.89 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $305B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.